How did the first COVID-19 lockdown affect persons with concurrent mental health and substance use disorders in Norway? A qualitative study.
COVID-19
Lockdown
Mental health disorder
Qualitative study
Substance use disorder
Thematic analysis
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
14 03 2022
14 03 2022
Historique:
received:
28
06
2021
accepted:
24
02
2022
entrez:
15
3
2022
pubmed:
16
3
2022
medline:
25
3
2022
Statut:
epublish
Résumé
The outbreak of COVID-19 with its severe social restrictions touched the daily life of most people. While everyday social life becomes difficult for citizens with economic and cultural capital, it becomes even worse for vulnerable groups such as persons with mental health and substance use disorders, who are particularly vulnerable to social exclusion. The aim of this study is to investigate how the first COVID-19 lockdown affected the everyday life and health of persons with co-occurring mental health and substance use disorders. This qualitative study reports data from 17 individual interviews and one focus group of five participants, all with a self-reported mental health and substance use disorder. Interviews were conducted based on a semi-structured interview guide in September and October 2020 in a medium-sized local authority in Norway. Data were analysed using thematic analysis. A reference group of people with varied knowledge and experiences of the phenomenon were involved in study design, recruitment, data generation and analysis. The analysis identified four interrelated main themes, describing how the first lockdown affected the everyday life and health of persons suffering from a mental health and substance use disorder: (1) The COVID-19 outbreak as a perceived challenge, (2) A decline in mental health and well-being, (3) Increased substance use challenges, and (4) Diverse experiences with health and social services. The results show that people with a co-occurring disorder have challenges with digital tools and/or do not have the appropriate equipment. Further, participants were not concerned about becoming infected themselves, but infecting others. Persons with a mental health and substance use disorder face major challenges during the COVID-19 pandemic. There is a need to maintain continuous low-threshold services especially directed towards persons with co-occurring disorders during the pandemic. Furthermore, it is important to improve the digital skills of every service user or offer alternatives to digital consultations and meetings.
Sections du résumé
BACKGROUND
The outbreak of COVID-19 with its severe social restrictions touched the daily life of most people. While everyday social life becomes difficult for citizens with economic and cultural capital, it becomes even worse for vulnerable groups such as persons with mental health and substance use disorders, who are particularly vulnerable to social exclusion. The aim of this study is to investigate how the first COVID-19 lockdown affected the everyday life and health of persons with co-occurring mental health and substance use disorders.
METHODS
This qualitative study reports data from 17 individual interviews and one focus group of five participants, all with a self-reported mental health and substance use disorder. Interviews were conducted based on a semi-structured interview guide in September and October 2020 in a medium-sized local authority in Norway. Data were analysed using thematic analysis. A reference group of people with varied knowledge and experiences of the phenomenon were involved in study design, recruitment, data generation and analysis.
RESULTS
The analysis identified four interrelated main themes, describing how the first lockdown affected the everyday life and health of persons suffering from a mental health and substance use disorder: (1) The COVID-19 outbreak as a perceived challenge, (2) A decline in mental health and well-being, (3) Increased substance use challenges, and (4) Diverse experiences with health and social services. The results show that people with a co-occurring disorder have challenges with digital tools and/or do not have the appropriate equipment. Further, participants were not concerned about becoming infected themselves, but infecting others.
CONCLUSIONS
Persons with a mental health and substance use disorder face major challenges during the COVID-19 pandemic. There is a need to maintain continuous low-threshold services especially directed towards persons with co-occurring disorders during the pandemic. Furthermore, it is important to improve the digital skills of every service user or offer alternatives to digital consultations and meetings.
Identifiants
pubmed: 35287637
doi: 10.1186/s12888-022-03812-7
pii: 10.1186/s12888-022-03812-7
pmc: PMC8919911
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
179Informations de copyright
© 2022. The Author(s).
Références
Lancet Psychiatry. 2020 Apr;7(4):e21
pubmed: 32199510
Int J Environ Res Public Health. 2021 Jun 06;18(11):
pubmed: 34204043
J Subst Abuse Treat. 2019 Jan;96:46-52
pubmed: 30466548
Int J Environ Res Public Health. 2020 Aug 31;17(17):
pubmed: 32878180
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
J Ment Health. 2021 Jun;30(3):358-365
pubmed: 32762384
Lancet Psychiatry. 2020 Jun;7(6):476-477
pubmed: 32407671
AIDS Behav. 2021 Feb;25(2):354-359
pubmed: 32705370
J Affect Disord. 2020 Dec 1;277:55-64
pubmed: 32799105
Psychiatr Rehabil J. 2004 Spring;27(4):360-74
pubmed: 15222148
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Fam Med Community Health. 2019 Mar 8;7(2):e000057
pubmed: 32148704
Psychiatr Danub. 2016 Sep;28(Suppl-1):125-131
pubmed: 27663822
Int J Ment Health Addict. 2018;16(1):53-65
pubmed: 29491766
Indian J Tuberc. 2020 Jul;67(3):284-285
pubmed: 32825854
Lancet Psychiatry. 2021 Jul;8(7):610-619
pubmed: 33965057
Health Policy Technol. 2020 Dec;9(4):663-672
pubmed: 32874857
Lancet Psychiatry. 2020 May;7(5):390-391
pubmed: 32353270
J Subst Abuse Treat. 2020 May;112:10-16
pubmed: 32199540
Drug Alcohol Depend. 2020 Dec 1;217:108302
pubmed: 32961453
Lancet Psychiatry. 2020 Sep;7(9):813-824
pubmed: 32682460
Int J Soc Psychiatry. 2018 Jun;64(4):374-380
pubmed: 29595350
J Ment Health. 2011 Feb;20(1):60-9
pubmed: 21271827
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070
pubmed: 32800868
J Am Med Inform Assoc. 2020 Jul 1;27(7):1132-1135
pubmed: 32324855
Res Involv Engagem. 2020 Jun 26;6:36
pubmed: 32601547
World Psychiatry. 2011 Jun;10(2):138-51
pubmed: 21633691
Pharmaceuticals (Basel). 2020 Jul 18;13(7):
pubmed: 32708495
Sleep Med. 2021 Nov;87:38-45
pubmed: 34508986
Lancet Public Health. 2020 May;5(5):e249-e250
pubmed: 32302535
Environ Int. 2021 Aug;153:106540
pubmed: 33838618
West J Emerg Med. 2018 Nov;19(6):902-906
pubmed: 30429919
Eur Addict Res. 2021;27(4):257-262
pubmed: 33839730
Soc Psychiatry Psychiatr Epidemiol. 2021 Jun;56(6):1113
pubmed: 33839806
J Epidemiol Community Health. 2017 Jan;71(1):4-11
pubmed: 27298424
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Tidsskr Nor Laegeforen. 2015 Feb 10;135(3):246-8
pubmed: 25668543